On June 17, 2026, The Mosaic Company (ticker: MOS) garnered a “Buy” rating from Vitaly Kononov of Freedom Broker, marking a significant endorsement for investors. This rating arrives during a period of market volatility, suggesting that there may be untapped upside potential for the stock, especially as its current trading price of $22.51 sits well

On June 17, 2026, Huntsman Corporation (NYSE: HUN) received a Neutral rating from John Roberts of Mizuho, a rating that comes with a price target of $14, aligning closely with its current trading price of $12.725. This decision brings into focus the wider implications for investors, particularly those considering the company as part of their

On June 17, 2026, Ermenegildo Zegna N.V. (NYSE: ZGN) received a Neutral rating from Goldman Sachs analyst Adrien Duverger. This rating aligns with Zegna’s current stock price of $14.49, presenting investors with a modest outlook at a price target of $14. While this marks a pause in aggressive bullish sentiment, it also provides a clearer

**Investors in ResMed Inc. (RMD) are currently navigating a recent rating adjustment from David Bailey of Morgan Stanley, who has updated the stock to an equal-weight rating as of June 17, 2026. This rating reflects a balanced outlook, suggesting that while the stock’s price has potential upside, investors should approach it with caution given the

On June 17, 2026, Rexford Industrial Realty, Inc. (REXR) saw its investment outlook downgraded to Underweight by JP Morgan’s Michael Mueller. This adjustment reflects a growing caution within the analyst community regarding the stock’s near-term potential, especially as it approaches its current trading price of $34.45. With a modest price target of $36 set by

In a notable development, BTIG analyst Douglas Harter upgraded TPG Mortgage Investment Trust Inc (MITT) to a “Buy” rating on June 17, 2026. This shift comes as the stock currently trades at $7.94, suggesting a potential upside toward the analyst’s price target of $9. For investors, this rating could signal increased confidence in the company’s

MFA Financial, Inc. (NYSE: MFA) has garnered fresh attention from the investment community following a recent initiation of coverage with a “Buy” rating by Douglas Harter of BTIG. This endorsement suggests a favorable outlook for the stock, particularly with a price target set at $10.50, implying notable upside potential from its current trading price of

On June 17, 2026, JP Morgan analyst Michael Mueller assigned a “Neutral” rating to The Macerich Company (MAC) while setting a price target of $25. This assessment comes at a time when the stock is trading at approximately $23.75, providing some modest upside potential for investors. As the retail real estate sector grapples with fluctuating

Leidos Holdings, Inc. (NASDAQ: LDOS) recently received a “Neutral” rating from BofA Securities analyst Mariana Perez, reflecting a more cautious outlook for the company amid a backdrop of otherwise solid performance indicators. The stock is currently valued at $113.58, with a price target set at $125, suggesting an upside potential that investors may wish to

On June 17, 2026, Kallum Titchmarsh from Morgan Stanley assigned an Equal-Weight rating to IQVIA Holdings Inc. (NYSE: IQV), indicating that the stock is expected to perform in line with the market. This rating comes as part of a broader analysis where Titchmarsh also introduced a price target of $200—a notable upside from the stock’s

In a significant move for investors, Charles River Laboratories International, Inc. (CRL) recently received an “Overweight” rating from Ricky Goldwasser of Morgan Stanley. Announced on June 17, 2026, this upgrade suggests a favorable outlook, especially with a price target set at $220, indicating substantial upside from the current trading level of $184.79. Recent Price Action

Carter’s, Inc. (NYSE: CRI) recently garnered attention as analyst Ike Boruchow from Wells Fargo initiated coverage with an Equal-Weight rating. This development reflects a cautious outlook, suggesting that while the stock’s price aligns closely with its target, larger macroeconomic factors may temper expectations. Investors seeking to navigate this landscape will find both promising upside and